Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Deraco

Showing results (41-50 of 67) with videos related to

Pageof 7
Sort By:
Updates in Surgery|May 23, 2022
Preliminary results of a program for the implementation of laparoscopic colorectal surgery in an Italian comprehensive cancer center during the COVID-19 pandemicD Baratti, L Battaglia, F Belli, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 1, 2015
The role of baseline inflammatory-based scores and serum tumor markers to risk stratify pseudomyxoma peritonei patients treated with cytoreduction (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC)S Kusamura, D Baratti, I Hutanu, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 13, 2025
Optimizing the pathological diagnosis of diffuse malignant peritoneal mesotheliomaF L Nava, S Kusamura, M Shimonovitz-Moore, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|May 11, 2012
Secondary cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for recurrent epithelial ovarian cancer: a multi-institutional studyM Deraco, S Virzì, D R Iusco, et al.
The British Journal of Surgery|October 21, 2014
Multicentre study of the learning curve and surgical performance of cytoreductive surgery with intraperitoneal chemotherapy for pseudomyxoma peritoneiS Kusamura, B J Moran, P H Sugarbaker, et al.
Journal of Experimental & Clinical Cancer Research : CR|June 14, 2006
Sitilo experience on peritoneal carcinomatosis from colorectal cancer: clinical prognostic featuresF Cavaliere, P Perri, C R Rossi, et al.
Tumori|February 24, 2001
Ovarian germ cell cancer: clinicopathologic analysis and outcome of 31 casesS Kusamura, L C Teixeira, M A dos Santos, et al.
Tumori|November 1, 1996
Treatment of recurrent sarcoma of the extremities by isolated limb perfusion using tumor necrosis factor alpha and melphalanM Santinami, M Deraco, A Azzarelli, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 20, 2006
Cytoreduction combined with intraperitoneal hyperthermic perfusion chemotherapy in advanced/recurrent ovarian cancer patients: The experience of National Cancer Institute of MilanF Raspagliesi, S Kusamura, J C Campos Torres, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 27, 2020
Peritoneal mesothelioma: PSOGI/EURACAN clinical practice guidelines for diagnosis, treatment and follow-upS Kusamura, V Kepenekian, L Villeneuve, et al.
Pageof 7

Showing results (41-50 of 67) with videos related to

Sort By:
Pageof 7
Updates in Surgery|May 23, 2022
Preliminary results of a program for the implementation of laparoscopic colorectal surgery in an Italian comprehensive cancer center during the COVID-19 pandemicD Baratti, L Battaglia, F Belli, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 1, 2015
The role of baseline inflammatory-based scores and serum tumor markers to risk stratify pseudomyxoma peritonei patients treated with cytoreduction (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC)S Kusamura, D Baratti, I Hutanu, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 13, 2025
Optimizing the pathological diagnosis of diffuse malignant peritoneal mesotheliomaF L Nava, S Kusamura, M Shimonovitz-Moore, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|May 11, 2012
Secondary cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for recurrent epithelial ovarian cancer: a multi-institutional studyM Deraco, S Virzì, D R Iusco, et al.
The British Journal of Surgery|October 21, 2014
Multicentre study of the learning curve and surgical performance of cytoreductive surgery with intraperitoneal chemotherapy for pseudomyxoma peritoneiS Kusamura, B J Moran, P H Sugarbaker, et al.
Journal of Experimental & Clinical Cancer Research : CR|June 14, 2006
Sitilo experience on peritoneal carcinomatosis from colorectal cancer: clinical prognostic featuresF Cavaliere, P Perri, C R Rossi, et al.
Tumori|February 24, 2001
Ovarian germ cell cancer: clinicopathologic analysis and outcome of 31 casesS Kusamura, L C Teixeira, M A dos Santos, et al.
Tumori|November 1, 1996
Treatment of recurrent sarcoma of the extremities by isolated limb perfusion using tumor necrosis factor alpha and melphalanM Santinami, M Deraco, A Azzarelli, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 20, 2006
Cytoreduction combined with intraperitoneal hyperthermic perfusion chemotherapy in advanced/recurrent ovarian cancer patients: The experience of National Cancer Institute of MilanF Raspagliesi, S Kusamura, J C Campos Torres, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 27, 2020
Peritoneal mesothelioma: PSOGI/EURACAN clinical practice guidelines for diagnosis, treatment and follow-upS Kusamura, V Kepenekian, L Villeneuve, et al.
Pageof 7